Tango Therapeutics, Inc. · NASDAQ:TNGX

Dapice Joshua J. reported a 7.80% stake in Tango Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 11, 2026

Dapice Joshua J. reported a 7.80% stake in Tango Therapeutics, Inc., 11,257,203 shares, as a passive investor on Mar 31, 2026. Filed May 11, 2026 (Schedule 13G/A).

Stake
7.80%
Shares
11,257,203
Intent
Passive
What changed
Stake changed
Filed together
28 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%1,055,717
Farallon Capital Institutional Partners, L.P.1.00%1,470,591
Farallon Capital Institutional Partners II, L.P.0.20%290,563
Farallon Capital Institutional Partners III, L.P.0.20%226,033
Four Crossings Institutional Partners V, L.P.0.20%260,503
Farallon Capital Offshore Investors II, L.P.1.70%2,488,434
Farallon Capital (AM) Investors, L.P.0.10%163,734
Farallon Capital F5 Master I, L.P.0.20%292,726
Farallon Healthcare Partners Master, L.P.3.50%5,008,902
Farallon Partners, L.L.C.7.60%10,964,477
Farallon Institutional (GP) V, L.L.C.0.20%260,503
Farallon F5 (GP), L.L.C.0.20%292,726
Farallon Healthcare Partners (GP), L.L.C.3.50%5,008,902
Dapice Joshua J.7.80%11,257,203
Dreyfuss, Philip D.7.80%11,257,203
Dunn Hannah E.7.80%11,257,203
Gehani, Varun N.7.80%11,257,203
Giauque, Nicolas7.80%11,257,203
Husen, Avner A.7.80%11,257,203
Kim, David T.7.80%11,257,203
Linn, Michael G.7.80%11,257,203
Luo Patrick (Cheng)7.80%11,257,203
Roberts, Jr., Thomas G.7.80%11,257,203
Saito Edric C.7.80%11,257,203
Short Daniel S.7.80%11,257,203
Spokes, Andrew J. M.7.80%11,257,203
Warren, John R.7.80%11,257,203
Wehrly, Mark C.7.80%11,257,203

Source

View original at SEC

Related